PreventionGenetics Hosting DNA Banking Day Tuesday November 29, 2016

Published on

Marshfield, WI – The U.S. Surgeon General has declared Thanksgiving to be “National Family Health History Day.”  To help promote awareness of family health history, PreventionGenetics, a clinical laboratory in Marshfield, is offering a DNA Banking Day from 3 - 6 p.m. on Tuesday, November 29, at the company headquarters in the Marshfield Mill Creek Business Park, 3800 South Business Park Avenue.  For more information about DNA banking, visit:

Finding Answers: Comprehensive Fetal and Neonatal Loss Panel

Published on

When families experience miscarriage, stillbirth, and neonatal loss, there are often many difficult questions. Why did this happen? Will it happen again? Is there anything that could have prevented the outcome? At PreventionGenetics, we are dedicated to helping answer these questions.

President's Corner - Connect to Quality

Published on

Some say that clinical DNA testing has become a commodity – that price should be the only factor in choosing a lab.  But I don’t buy it.  I think that quality is still very important in clinical DNA testing.    

Comparing labs in terms of quality is difficult.  It’s really hard for a client to distinguish a lab with say 95% correct reports to one with 99.7% correct reports (I define a correct report as one with no significant data errors and no major errors in interpretation).  To accurately compare such labs one would need to send hundreds of tests and probably hire a third or even fourth lab to verify the results.  A more practical approach might be to send a few particularly tough cases to multiple labs, but even that would be expensive, and as scientists, we know that drawing conclusions from limited data is unreliable.   

Value has improved for our Noonan Spectrum Disorders/Rasopathies Panel

Published on

We're excited to announce that our Noonan Spectrum Disorders/Rasopathies panel now has additional genes and a new lower price.

Opening Doors to Diagnosis: Chromosomal Microarray

Published on

We are pleased to announce new reduced pricing for our Chromosomal Microarray (CMA). CMA is often used as a first-tier test for clinical diagnosis of patients with idiopathic intellectual disability, developmental delay, autism spectrum disorders and/or multiple congenital anomalies (Miller, D.T. et al. 2010).